PIM

Partner Investment Management Portfolio holdings

AUM $13.9M Turnover 66.25%
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+15.92%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$67.5M
AUM Growth
+$6.33M
Cap. Flow
+$5.94M
Cap. Flow %
8.8%
Top 10 Hldgs %
31.63%
Holding
112
New
35
Increased
20
Reduced
22
Closed
29
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
VYGR icon
Voyager Therapeutics
VYGR
+$1.84M
2
UNP icon
Union Pacific
UNP
+$1.69M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.51M
4
AAPL icon
Apple
AAPL
+$1.4M
5
BIIB icon
Biogen
BIIB
+$1.39M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$2.28M
2
AMAT icon
Applied Materials
AMAT
+$1.53M
3
ABBV icon
AbbVie
ABBV
+$1.13M
4
MCK icon
McKesson
MCK
+$1.11M
5
ALDR
Alder Biopharmaceuticals
ALDR
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 48.82%
2 Miscellaneous 11.48%
3 Technology 10.99%
4 Communication Services 8.2%
5 Consumer Discretionary 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BIIB icon
1
Biogen
BIIB
$34.3B
$3.7M 5.49%
11,828
+4,689
+66% +$1.39M
2016 Q2
1 quarter
JAZZ icon
2
Jazz Pharmaceuticals
JAZZ
$13.6B
$2.6M 3.85%
21,391
+11,182
+110% +$1.51M
2015 Q1
6 quarters
EW icon
3
Edwards Lifesciences
EW
$49.8B
$2.37M 3.52%
59,079
-8,970
-13% -$338K
2014 Q4
7 quarters
WBA icon
4
DELISTED
Walgreens Boots Alliance
WBA
$2.01M 2.98%
24,899
+7,174
+40% +$585K
2014 Q4
7 quarters
META icon
5
Meta Platforms (Facebook)
META
$1.88T
$2.01M 2.97%
15,640
+2,045
+15% +$254K
2013 Q4
11 quarters
VYGR icon
6
Voyager Therapeutics
VYGR
$123M
$1.95M 2.89%
162,278
+136,091
+520% +$1.84M
2015 Q4
3 quarters
UNP icon
7
Union Pacific
UNP
$169B
$1.76M 2.6%
+18,018
New +$1.69M
2016 Q3
0 quarters
AAPL icon
8
Apple
AAPL
$5.01T
$1.74M 2.58%
61,560
+52,732
+597% +$1.4M
2016 Q1
2 quarters
AERI
9
DELISTED
Aerie Pharmaceuticals
AERI
$1.6M 2.37%
42,438
-1,907
-4% -$42.1K
2015 Q1
6 quarters
BAX icon
10
Baxter International
BAX
$12.8B
$1.6M 2.37%
33,609
+5,805
+21% +$274K
2016 Q2
1 quarter
DISH
11
DELISTED
DISH Network Corp.
DISH
$1.49M 2.21%
27,158
+6,912
+34% +$358K
2016 Q2
1 quarter
BMRN icon
12
BioMarin Pharmaceuticals
BMRN
$10.7B
$1.45M 2.15%
15,635
+3,883
+33% +$366K
2016 Q2
1 quarter
PANW icon
13
Palo Alto Networks
PANW
$307B
$1.41M 2.08%
52,902
+20,340
+62% +$464K
2014 Q2
9 quarters
ALDR
14
DELISTED
Alder Biopharmaceuticals
ALDR
$1.38M 2.04%
41,960
-33,042
-44% -$1.01M
2014 Q2
9 quarters
MDCO
15
DELISTED
Medicines Co
MDCO
$1.37M 2.03%
36,352
-14,456
-28% -$545K
2015 Q2
5 quarters
NOW icon
16
ServiceNow
NOW
$145B
$1.19M 1.76%
+74,985
New +$1.11M
2016 Q3
0 quarters
V icon
17
Visa
V
$733B
$1.15M 1.7%
13,901
+9,919
+249% +$794K
2016 Q2
1 quarter
PXD icon
18
DELISTED
Pioneer Natural Resource Co.
PXD
$1.14M 1.69%
+6,132
New +$1.04M
2016 Q3
0 quarters
LLY icon
19
CALL
Eli Lilly
LLY
$1.08T
$1.11M 1.64%
+13,800
New +$1.1M
2016 Q3
0 quarters
BMY icon
20
PUT
Bristol-Myers Squibb
BMY
$121B
$1.08M 1.61%
+20,100
New +$1.29M
2016 Q3
0 quarters
HUM icon
21
Humana
HUM
$51.2B
$1.04M 1.54%
+5,886
New +$1.02M
2016 Q3
0 quarters
BKD icon
22
Brookdale Senior Living
BKD
$2.4B
$1.01M 1.5%
58,009
-9,752
-14% -$168K
2016 Q1
2 quarters
HRTX icon
23
Heron Therapeutics
HRTX
$69M
$969K 1.44%
56,258
+7,979
+17% +$148K
2015 Q2
5 quarters
RRC icon
24
Range Resources
RRC
$9.76B
$960K 1.42%
+24,771
New +$1M
2016 Q3
0 quarters
CME icon
25
CME Group
CME
$103B
$945K 1.4%
+9,042
New +$944K
2016 Q3
0 quarters
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2016 Portfolio in Review

As of Q3 2016, Partner Investment Management held 112 positions worth $67.5M, up 10% from $61.1M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Partner Investment Management deployed $5.94M of net new capital in Q3 2016, opening 35 new positions and adding to 20 existing holdings. Its largest new stake was Union Pacific: 18,018 shares worth $1.76M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 46% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was AbbVie, an estimated $1.13M trimmed.

  • Partner Investment Management's largest Q3 2016 buy was Union Pacific: 18,018 shares worth $1.76M.
  • Partner Investment Management added most to Voyager Therapeutics in Q3 2016, an estimated $1.84M increase.
  • Partner Investment Management's biggest Q3 2016 reduction was AbbVie, cutting an estimated $1.13M.
  • Partner Investment Management fully exited Aetna Inc in Q3 2016, selling an estimated $2.28M.
  • Partner Investment Management's ten largest holdings make up 32% of its $67.5M portfolio in Q3 2016.
  • Partner Investment Management opened 35 new positions and closed 29 in Q3 2016.
  • Partner Investment Management's portfolio value rose 10% quarter-over-quarter to $67.5M.

Based on Partner Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.